This trial is active, not recruiting.

Condition joint effusion
Treatment infrared spectroscopy
Sponsor Rennes University Hospital
Start date June 2014
End date August 2016
Trial size 600 participants
Trial identifier NCT02860871, 35RC13_8815


The main objective of this study is to assess the ability of Fiber-optic Evanescent Wave Spectroscopy (FEWS) to discriminate synovial fluids samples of septic arthritis patients from other causes of joint effusion by analyzing ex vivo joint fluid samples collected during routine clinical care.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Diagnosis of the cause of joint effusion
time frame: through study completion, an average of 6 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study - patients over 18 year old, - patients who received information about the protocol and have not expressed opposition to participate. Exclusion Criteria: - patients opposing the study, - patients aged below 18 year old - Protected major (safeguard justice , trusteeship and guardianship) and persons deprived of liberty

Additional Information

Official title Use of Infrared Spectroscopy in Septic Arthritis Diagnosis
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Rennes University Hospital.